Literature DB >> 18022981

Miuraenamides: antimicrobial cyclic depsipeptides isolated from a rare and slightly halophilic myxobacterium.

Makoto Ojika1, Yasutaka Inukai, Yuko Kito, Masayuki Hirata, Takashi Iizuka, Ryosuke Fudou.   

Abstract

Marine myxobacteria are rare culture-resistant microorganisms, several strains of which have been identified by research groups in Asia. Paraliomyxa miuraensis, a slightly halophilic myxobacterium discovered in Japan, produces the cyclic hybrid polyketide-peptide antibiotics known as miuraenamides A and B, whose taxonomical and biological characteristics have been reported previously. Herein, we describe the chemical characterization of these two miuraenamides and introduce four new members of the miuraenamide family. We carried out the complete structural analysis of miuraenamides A and B on the basis of NMR spectroscopic analysis and elucidated the absolute configuration of miuraenamide A by chemical derivatization and subsequent use of the modified Mosher method or the Marfey method. Miuraenamides C-F were isolated from the same strain of the bacterium as miuraenamides A and B. The structure-antimicrobial-activity relationships of the six natural metabolites and four chemically derived compounds demonstrated the importance of both the macrocyclic structure and the beta-methoxyacrylate moiety.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18022981     DOI: 10.1002/asia.200700233

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  14 in total

1.  Quorum-sensing inhibitory compounds from extremophilic microorganisms isolated from a hypersaline cyanobacterial mat.

Authors:  Raeid M M Abed; Sergey Dobretsov; Marwan Al-Fori; Sarath P Gunasekera; Kumar Sudesh; Valerie J Paul
Journal:  J Ind Microbiol Biotechnol       Date:  2013-05-05       Impact factor: 3.346

2.  N-Heterocyclic carbene-catalyzed direct cross-aza-benzoin reaction: Efficient synthesis of α-amino-β-keto esters.

Authors:  Takuya Uno; Yusuke Kobayashi; Yoshiji Takemoto
Journal:  Beilstein J Org Chem       Date:  2012-09-10       Impact factor: 2.883

Review 3.  Marine peptides and their anti-infective activities.

Authors:  Hee Kyoung Kang; Chang Ho Seo; Yoonkyung Park
Journal:  Mar Drugs       Date:  2015-01-16       Impact factor: 5.118

4.  Heterologous Production of the Marine Myxobacterial Antibiotic Haliangicin and Its Unnatural Analogues Generated by Engineering of the Biochemical Pathway.

Authors:  Yuwei Sun; Zhiyang Feng; Tomohiko Tomura; Akira Suzuki; Seishi Miyano; Takashi Tsuge; Hitoshi Mori; Joo-Won Suh; Takashi Iizuka; Ryosuke Fudou; Makoto Ojika
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

5.  An Unusual Diterpene-Enhygromic Acid and Deoxyenhygrolides from a Marine Myxobacterium, Enhygromyxa sp.

Authors:  Tomohiko Tomura; Shiori Nagashima; Satoshi Yamazaki; Takashi Iizuka; Ryosuke Fudou; Makoto Ojika
Journal:  Mar Drugs       Date:  2017-04-06       Impact factor: 5.118

Review 6.  Future Directions of Marine Myxobacterial Natural Product Discovery Inferred from Metagenomics.

Authors:  Ronald Garcia; James J La Clair; Rolf Müller
Journal:  Mar Drugs       Date:  2018-08-29       Impact factor: 5.118

Review 7.  Antimicrobial peptides from marine proteobacteria.

Authors:  Florie Desriac; Camille Jégou; Eric Balnois; Benjamin Brillet; Patrick Le Chevalier; Yannick Fleury
Journal:  Mar Drugs       Date:  2013-09-30       Impact factor: 5.118

Review 8.  Marine-derived myxobacteria of the suborder Nannocystineae: An underexplored source of structurally intriguing and biologically active metabolites.

Authors:  Antonio Dávila-Céspedes; Peter Hufendiek; Max Crüsemann; Till F Schäberle; Gabriele M König
Journal:  Beilstein J Org Chem       Date:  2016-05-13       Impact factor: 2.883

Review 9.  Metabolic and Biosynthetic Diversity in Marine Myxobacteria.

Authors:  Katja Gemperlein; Nestor Zaburannyi; Ronald Garcia; James J La Clair; Rolf Müller
Journal:  Mar Drugs       Date:  2018-09-05       Impact factor: 5.118

Review 10.  Marine Myxobacteria: A Few Good Halophiles.

Authors:  Hanan Albataineh; D Cole Stevens
Journal:  Mar Drugs       Date:  2018-06-14       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.